📜 The AlphaFold Revolution: Why Bio-AI Patents Could Be Your Next Million-Dollar Bet

Your Weekly Shortcut to Deeptech Investing—Exclusive Trends & Startup Reports for VCs & Angels in Just 5 Minutes Invest Deeptech

Hey deeptech investors—Eden, here. I’m ready to unpack an interesting story for you. Imagine you’re a detective, but instead of solving crimes, you’re cracking the code of diseases. For years, scientists struggled to understand proteins—the key clues in this puzzle. It took millions of dollars and years of work, and even then, success wasn’t guaranteed. Then, in 2021, DeepMind’s AlphaFold changed the game. It mapped 98.5% of human proteins and made the data public, turning biotech’s biggest mystery into an open book. For investors like us, it’s as if someone just handed us a treasure map.

But let’s keep it real: there’s no blockbuster “AlphaFold patent” to grab just yet. DeepMind is playing the long game, holding back from a single golden-ticket patent. But what they have done is spark a biotech revolution— and trust me, the spark is setting Bio-AI patents on fire.

Here’s why this matters, how it’s transforming drug discovery, and—most importantly—how you can position yourself before the rest of the market wakes up.

Let’s dive in.👇

🔓If you haven’t yet, [upgrade now —>] to master Deeptech Secrets and 10x your portfolio.